Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tatiana V. Kudling, James H.A. Clubb, Santeri Pakola, Dafne C.A. Quixabeira, Iris A.K. Lähdeniemi, Camilla Heiniö, Victor Arias, Riikka Havunen, Victor Cervera-Carrascon, Joao M. Santos, Eva Sutinen, Jari Räsänen, Kristian Borenius, Mikko I. Mäyränpää, Eero Aaltonen, Suvi Sorsa, Otto Hemminki, Anna Kanerva, Emmy W. Verschuren, Ilkka Ilonen & Akseli Hemminki. (2023) Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer. OncoImmunology 12:1.
Read now
Read now
Articles from other publishers (6)
Sara Witting Christensen Wen, Line Nederby, Rikke Fredslund Andersen, Torben Schjødt Hansen, Christa Haugaard Nyhus, Ole Hilberg, Anders Jakobsen & Torben Frøstrup Hansen. (2023) NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. British Journal of Cancer 129:1, pages 135-142.
Crossref
Crossref
Jing Ding, Yan Zhang & Yan Che. (2022) Ovarian cancer stem cells: Critical roles in anti-tumor immunity. Frontiers in Genetics 13.
Crossref
Crossref
Éilis Russell, Melissa J. Conroy & Martin P. Barr. (2022) Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer. Cells 11:4, pages 605.
Crossref
Crossref
Eun Jae Park, Hye Won Jun, Ik Ho Na, Hong Kyung Lee, Jieun Yun, Hyung Sook Kim, Youngsoo Kim, Jin Tae Hong & Sang-Bae Han. (2021) CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity. Archives of Pharmacal Research 45:1, pages 1-10.
Crossref
Crossref
Elena V. Abakushina, Liubov I. Popova, Andrey A. ZamyatninJr.Jr., Jens Werner, Nikolay V. Mikhailovsky & Alexandr V. Bazhin. (2021) The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy. Vaccines 9:11, pages 1363.
Crossref
Crossref
Carl Randall Harrell, Ana Volarevic, Valentin G. Djonov, Nemanja Jovicic & Vladislav Volarevic. (2021) Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. International Journal of Molecular Sciences 22:22, pages 12429.
Crossref
Crossref